Hansa Biopharma’s SEK 415.9 Million Directed Share Issue

Vinge has advised Hansa Biopharma on the deal.Hansa Biopharma announced directed share issue through which the company raises proceeds of SEK 415.9 million before transaction costs. Through…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now